Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Thursday newspaper round-up: Telegraph, AstraZeneca, Boeing

(Sharecast News) - The government has said it intends to launch a second investigation into the Barclay family's complex deal to transfer control of the Telegraph, after its Abu Dhabi-backed consortium partner revealed a last-minute corporate structure change that has raised public interest concerns. The culture secretary, Lucy Frazer, said she was "minded to" issue a new public interest intervention notice (PIIN) to call in the regulators Ofcom and the Competition and Markets Authority (CMA) to look at RedBird IMI's move to create a new UK holding company to house the Telegraph and its sister magazine, The Spectator, when it takes control of the titles. - Guardian Despite putting a new vehicle on the market, announcing another for 2025 and beating Wall Street's expectations for vehicle deliveries, Tesla was not able to shake off its disappointing third quarter. The electric vehicle manufacturer brought in $25.1bn in revenue and posted $.71 in earnings a share in the fourth quarter of 2023, missing analyst expectations of 25.76bn in revenue and $0.74 earnings a share. The company's fourth quarter revenue increased 3% year over year from $24.3bn in 2022. - Guardian

UK electricity prices have risen faster than almost any other developed country since 2019, the International Energy Agency (IEA) has found. Soaring wholesale costs and an increase in net zero levies have led to British households paying more for their power, as they now face the third highest prices in Europe. - Telegraph

AstraZeneca is seeking up to £100 million in government support to expand a vaccine production facility in northwest England. In a potential boost for both British manufacturing and the life sciences sector, the UK's most valuable public company plans to submit a formal application next month to gain access to public funding to help to develop its nasal flu vaccines plant in Speke, near Liverpool. - The Times

The boss of Boeing said yesterday that the manufacturer would support the operation of its aircraft only if it was "100 per cent" confident in their safety after a federal regulator grounded some of its 737 Max 9 fleet. Dave Calhoun, the company's chief executive, who was in Washington for meetings with senators, said: "We don't put planes in the air that we don't have 100 per cent confidence in." He said that Boeing fully understood "the gravity of the situation". - The Times

Share this article

Related Sharecast Articles

Thursday newspaper round-up: Thames Water, mortgage costs, UK car production
(Sharecast News) - Thames Water has breached its licence to supply water to nearly 16 million people after some of its debt was downgraded to junk status. The regulator Ofwat could now fine Thames, the country's largest water monopoly, up to 10% of its annual turnover, equating to hundreds of millions of pounds. However, since the company is already teetering close to temporary renationalisation, Ofwat is likely to hold off on any immediate large fines. - Guardian
Wednesday newspaper round-up: Reckitt, Tesla, Virgin Atlantic...
(Sharecast News) - Reckitt is under pressure from top shareholders to revisit a sale of its nutrition business, following litigation and a series of other setbacks at the division that have sent the company's share price to decade lows. The FTSE 100 consumer giant acquired the Mead Johnson infant formula business in 2017 for $17bn - its largest-ever acquisition - and it has been plagued by mishaps ever since. Meanwhile, the wider group, which makes Lysol detergent and Durex condoms, has underwhelmed investors as it struggles to build back sales volumes following a period of high inflation and suppressed consumer demand. - Financial Times
Tuesday newspaper round-up: Kamala Harris, Crowdstrike, Vivendi...
(Sharecast News) - Kamala Harris has secured enough delegates from her party to clinch the Democratic presidential nomination, as she pledged to offer Americans a "brighter future" compared to the "chaos, fear and hate" proposed by Donald Trump. The US vice-president was speaking in Wilmington, Delaware, on Monday, the first full day since President Joe Biden dropped his re-election bid and endorsed her for the Democratic presidential nomination, shaking up the 2024 race for the White House. - Financial Times
Monday newspaper round-up: Biden, gambling levy, UK economy...
(Sharecast News) - Kamala Harris, the vice-president, has emerged as the frontrunner to replace President Biden as the Democratic nominee for the election against Donald Trump in November. Biden, 81, announced yesterday afternoon that he would drop out of the race. In the hours that followed, Harris, 59, was endorsed by leading Democrats, prospective rivals and the chairs of all 50 state parties. - The Times

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.